Ischemic Preconditioning Ineffectual Before Cardiac Surgery
|
By HospiMedica International staff writers Posted on 25 Oct 2015 |
|
A new study suggests that cycles of upper arm remote ischemic preconditioning (RIPC) before heart surgery has no effect on outcomes.
Researchers at University Hospital Frankfurt (Germany), University Hospital Göttingen (Germany) and other institutions in Germany conducted a prospective, randomized trial involving 1,385 adults (692 study cohort and 693 shams) scheduled for elective cardiac surgery requiring cardiopulmonary bypass. The primary end point was a composite of death, myocardial infarction (MI), stroke, or acute renal failure up to hospital discharge. Secondary end points included the occurrence of any individual component of the primary end point by day 90.
The results showed no significant between-group difference in the rate of the composite primary end point, or of any of the individual components; the results were similar in the per-protocol analysis, and no treatment effect was found in any subgroup analysis. No significant differences between the RIPC group and the sham-RIPC group were seen in level of troponin release, duration of mechanical ventilation, length of stay in the ICU or the hospital, new onset of atrial fibrillation, and incidence of postoperative delirium. No RIPC-related adverse events were observed. The study was published on October 8, 2015, in the New England Journal of Medicine (NEJM).
“The preconditioning protocol had no impact on the primary composite endpoint of death, MI, stroke, or acute renal failure up to the time of hospital discharge, compared with sham conditioning before elective cardiac surgery requiring cardiopulmonary bypass,” concluded lead author Patrick Meybohm, MD, of University Hospital Frankfurt, and colleagues. “Negative findings did not rule out a possible benefit from other remote ischemic preconditioning protocols, such as those done on lower limbs, with a longer duration of ischemia, or more cycles of preconditioning.”
RIPC involves repetitive cycles of transient ischemia of non-vital tissue to help remote vital organs withstand a subsequent prolonged ischemic event and the eventual reperfusion. It usually consists of 3¬–4 five-minute cycles of right upper arm ischemia, induced by an automated cuff inflated to 200 mmHg, with an intervening five minutes of reperfusion during which the cuff is deflated.
Related Links:
University Hospital Frankfurt
University Hospital Göttingen
Researchers at University Hospital Frankfurt (Germany), University Hospital Göttingen (Germany) and other institutions in Germany conducted a prospective, randomized trial involving 1,385 adults (692 study cohort and 693 shams) scheduled for elective cardiac surgery requiring cardiopulmonary bypass. The primary end point was a composite of death, myocardial infarction (MI), stroke, or acute renal failure up to hospital discharge. Secondary end points included the occurrence of any individual component of the primary end point by day 90.
The results showed no significant between-group difference in the rate of the composite primary end point, or of any of the individual components; the results were similar in the per-protocol analysis, and no treatment effect was found in any subgroup analysis. No significant differences between the RIPC group and the sham-RIPC group were seen in level of troponin release, duration of mechanical ventilation, length of stay in the ICU or the hospital, new onset of atrial fibrillation, and incidence of postoperative delirium. No RIPC-related adverse events were observed. The study was published on October 8, 2015, in the New England Journal of Medicine (NEJM).
“The preconditioning protocol had no impact on the primary composite endpoint of death, MI, stroke, or acute renal failure up to the time of hospital discharge, compared with sham conditioning before elective cardiac surgery requiring cardiopulmonary bypass,” concluded lead author Patrick Meybohm, MD, of University Hospital Frankfurt, and colleagues. “Negative findings did not rule out a possible benefit from other remote ischemic preconditioning protocols, such as those done on lower limbs, with a longer duration of ischemia, or more cycles of preconditioning.”
RIPC involves repetitive cycles of transient ischemia of non-vital tissue to help remote vital organs withstand a subsequent prolonged ischemic event and the eventual reperfusion. It usually consists of 3¬–4 five-minute cycles of right upper arm ischemia, induced by an automated cuff inflated to 200 mmHg, with an intervening five minutes of reperfusion during which the cuff is deflated.
Related Links:
University Hospital Frankfurt
University Hospital Göttingen
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Vessel Sealing Instrument
ERGOseal
Monitor/Defibrillator
Zenix
Latest Surgical Techniques News
- Dual-Mobility Hip Implant Cuts Postoperative Dislocations
- Low-Frequency Ultrasound Selectively Targets Oral Cancer Cells
- Aortic Arch Remodeling Device Improves Type I Dissection Repair
- Intravesical CAR T Therapy Shows Promise for Bladder Cancer Treatment
- AI Tool Predicts Surgical Scheduling Gaps to Improve OR Utilization
- Living Valve Surgery Delivers Durable Outcomes for Aortic Valve Disease
- Innovative Central Line System Reduces Steps and Procedure Time
- Minimally Invasive Embolization Procedure Reduces Knee Osteoarthritis Pain
- Rapid AI OCT System Detects Malignant Liver Tissue Intraoperatively
- Automated EMR-Based Tool Detects Immune-Related Colitis in Immunotherapy Patients
- Personalized Cartilage Graft Offers New Option for Infants with Severe Airway Narrowing
- Minimally Invasive Procedure Reduces Knee Osteoarthritis Pain
- Computer-Assisted Vacuum Thrombectomy System Cleared for Stroke Care
- Near-Infrared Exoscope Enables Real-Time Perfusion Assessment and Lymphatic Mapping in Open Surgery
- Expandable Lumbar Fusion System Gains FDA 510(k) Clearance
- 3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Channels
Artificial Intelligence
view channel
AI Trends Report Guides Responsible, Effective Healthcare Deployment
Hospitals are under growing pressure to adopt artificial intelligence tools that improve safety, efficiency, and continuity of care without compromising quality. At the same time, clinicians need clearer... Read more
Privacy-Preserving AI Protects Sensitive Information in ECG Data
Artificial intelligence applied to electrocardiography can extract more than cardiac rhythm. Algorithms can infer age, sex, race, and even identity from electrocardiogram (ECG) signals, creating privacy... Read more
Critical Care
view channel
ECG-Based Screening Framework Aims to Standardize Cardiac Evaluation in Military Personnel
Sudden cardiac death, the unexpected loss of heart function, can occur during intense exertion and remains a concern in physically demanding occupations. Military personnel face additional environmental... Read more
RFA Device Gains FDA Clearance for Minimally Invasive Thyroid Nodule Ablation
STARMED America received U.S. Food and Drug Administration (FDA) 510(k) clearance for the VIVA combo RF generator used with star RF Electrodes and VIVA RF Electrodes, representing the first device indication... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
Atrial fibrillation is an erratic, quivering heartbeat and a leading cause of stroke. Catheter ablation is widely used to interrupt arrhythmogenic tissue, yet many patients—especially with persistent ... Read more
AI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
Artificial intelligence (AI) is increasingly used to estimate risks for conditions such as sepsis, heart disease, and cancer, yet many models remain difficult for clinicians to interpret or trust.... Read more
Point of Care
view channel
Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
Rapid access to diagnostic imaging is essential across hospitals, emergency departments, clinics, and municipal health systems, but large markets still face uneven availability, particularly in rural regions.... Read more
AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
Keratinocyte skin cancers, including basal cell and squamous cell carcinoma, account for a substantial share of dermatology workload in the United States and require accurate triage to guide biopsy decisions.... Read more
Business
view channel
Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
Danaher Corporation (Washington, DC, USA) has completed its acquisition of Masimo Corporation (Irvine, CA, USA), a specialty diagnostics provider known for pulse oximetry and advanced patient monitoring... Read more
